Skip to content
Evigrade
MajorLong-acting dopamine D2 receptor agonist, ergot derivative×Selective serotonin reuptake inhibitors (SSRIs)

Updated · Methodology

Mechanism

Sertraline potentiates serotonergic activity in the central nervous system by inhibiting neuronal reuptake of serotonin (Zoloft label, US Food and Drug Administration, FDA). Cabergoline is an ergot derivative that directly stimulates dopamine D2 receptors (Dostinex SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). The Spanish sertraline SmPC asks for caution with medicines that potentiate serotonergic neurotransmission and says such combinations should be avoided whenever possible. Among its examples, it names serotonin (5-HT) receptor agonists (Besitran SmPC, AEMPS). The Spanish cabergoline SmPC describes cabergoline as an ergot derivative with agonist activity at the serotonin 5-HT2B receptor. Fibrotic changes of serous membranes and heart valve disease have been seen after long-term use of such drugs (Dostinex SmPC, AEMPS). The US cabergoline label states that, in receptor-binding studies, cabergoline has low affinity for 5-HT1 and 5-HT2 serotonin receptors (cabergoline label, FDA). Their metabolic routes do not overlap. Cabergoline is broken down mainly by hydrolysis (FDA), while sertraline is a mild-to-moderate CYP2D6 inhibitor and does not inhibit CYP3A4 to a clinically significant degree (Besitran SmPC, AEMPS).

Symptoms

The documents describe no cases linked to this combination. The sertraline documents warn that the risk of serotonin syndrome rises with other serotonergic drugs. Its signs are agitation, hallucinations, delirium, tachycardia, labile blood pressure, sweating, hyperthermia, tremor, rigidity, myoclonus, hyperreflexia, seizures, nausea, vomiting and diarrhoea (Besitran SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS; Zoloft label, US Food and Drug Administration, FDA). Cabergoline itself commonly causes nausea, headache, dizziness, somnolence and postural hypotension. The Spanish SmPC also lists depression among its common adverse reactions (Dostinex SmPC, AEMPS).

Management

No document names this pair, so the severity level rests on a class statement in the Spanish sertraline SmPC. Medicines that potentiate serotonergic neurotransmission, including serotonin (5-HT) receptor agonists, are combined with sertraline with caution, and such combinations are avoided whenever possible (Besitran SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). Cabergoline falls into this class through its own Spanish SmPC, which describes it as a 5-HT2B receptor agonist (Dostinex SmPC, AEMPS). If the combination is clinically warranted, warn the patient about the increased risk of serotonin syndrome and monitor for its signs (Zoloft label, US Food and Drug Administration, FDA; Besitran SmPC, AEMPS). If signs of the syndrome appear, stop sertraline and the other serotonergic agent at once and start symptomatic treatment (Zoloft label, FDA). Cabergoline is used with caution in people with a history of serious mental illness, especially psychotic illness (Dostinex SmPC, AEMPS). Blood pressure is measured before cabergoline is started and during treatment, because cabergoline can cause postural hypotension (cabergoline label, FDA).

Your whole list in one report

Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email

Add more drugs

Medicine list: everything you take in one place →

Sources

Other interactions with Cabergoline

Other interactions with Sertraline